PTAB invalidates Sanofi injector patent

01-04-2021

Alex Baldwin

PTAB invalidates Sanofi injector patent

ricochet64 / Shutterstock.com

Mylan Pharmaceuticals has succeeded in getting the Patent Trial and Appeal board (PTAB) to invalidate an injector patent held by French pharmaceutical company Sanofi.


Mylan Pharmaceuticals, Sanofi, patent, PTAB

More on this story

Sanofi and C4X in $493m licensing deal
13-04-2021

LSIPR